Impact of adverse events of adjuvant and neoadjuvant chemotherapies on outcomes of patients with pancreatic ductal adenocarcinoma

被引：0
|
作者：
Shozo Mori
Taku Aoki
Yuhki Sakuraoka
Takayuki Shimizu
Takamune Yamaguchi
Kyung-Hwa Park
Takatsugu Matsumoto
Takayuki Shiraki
Yukihiro Iso
Keiichi Kubota
机构：
[1] Dokkyo Medical University,Department of Gastroenterological Surgery
来源：
Cancer Chemotherapy and Pharmacology | 2021年 / 88卷
关键词：
Pancreatic cancer; Neoadjuvant chemotherapy; Adjuvant chemotherapy; Gemcitabine; S-1;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：109 / 120
页数：11
相关论文
共 50 条
  • [21] Adjuvant and Neoadjuvant Radiochemotherapy in Ductal Pancreatic Carcinoma
    Thomas B. Brunner
    Gerhard G. Grabenbauer
    Ulrich Baum
    Werner Hohenberger
    Rolf Sauer
    Strahlentherapie und Onkologie, 2000, 176 : 265 - 273
  • [22] Impact of neoadjuvant therapy on gut microbiome in patients with resectable/borderline resectable pancreatic ductal adenocarcinoma
    Takaori, Ayaka
    Hashimoto, Daisuke
    Ikeura, Tsukasa
    Ito, Takashi
    Nakamaru, Koh
    Masuda, Masataka
    Nakayama, Shinji
    Yamaki, So
    Yamamoto, Tomohisa
    Fujimoto, Kosuke
    Matsuo, Yoshiyuki
    Akagawa, Shohei
    Ishida, Mitsuaki
    Yamaguchi, Kiyoshi
    Imoto, Seiya
    Hirota, Kiichi
    Uematsu, Satoshi
    Satoi, Sohei
    Sekimoto, Mitsugu
    Naganuma, Makoto
    PANCREATOLOGY, 2023, 23 (04) : 367 - 376
  • [23] Adjuvant and neoadjuvant radiochemotherapy in ductal pancreatic carcinoma
    Brunner, TB
    Grabenbauer, GG
    Baum, U
    Hohenberger, W
    Sauer, R
    STRAHLENTHERAPIE UND ONKOLOGIE, 2000, 176 (06) : 265 - 273
  • [24] The Impact of Sampling on Survival in Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreaticoduodenectomy
    Taherian, Mehran
    Katz, Matthew
    Prakash, Laura
    Tong, Yi Tat
    Lai, Zongshan
    Chatterjee, Deyali
    Wang, Hua
    Kim, Michael
    Tzeng, Ching-Wei
    Ikoma, Naruhiko
    Wolff, Robert A.
    Zhao, Dan
    Koay, Eugene
    Maitra, Anirban
    Wang, Huamin
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1529 - S1530
  • [25] Survival Benefit of Adjuvant Chemotherapy in Patients with Pancreatic Ductal Adenocarcinoma Who Underwent Surgery Following Neoadjuvant FOLFIRINOX
    Lee, So Heun
    Hwang, Dae Wook
    Yoo, Changhoon
    Kim, Kyu-pyo
    Kang, Sora
    Jeong, Jae Ho
    Oh, Dongwook
    Song, Tae Jun
    Lee, Sang Soo
    Park, Do Hyun
    Seo, Dong Wan
    Park, Jin-hong
    Song, Ki Byung
    Lee, Jae Hoon
    Lee, Woohyung
    Park, Yejong
    Kwak, Bong Jun
    Chang, Heung-Moon
    Ryoo, Baek-Yeol
    Kim, Song Cheol
    CANCER RESEARCH AND TREATMENT, 2023, 55 (03): : 956 - 968
  • [26] Clarifying the role of adjuvant therapy after multi-agent neoadjuvant chemotherapy for patients with pancreatic ductal adenocarcinoma
    Lan, Xiaoyang
    Abdel-Rahman, Omar
    TRANSLATIONAL CANCER RESEARCH, 2023, 12 (08) : 2232 - 2234
  • [27] Preoperative Biopsy Is Not Associated With Adverse Outcomes in Patients With Pancreatic Ductal Adenocarcinoma Undergoing Upfront Resection
    Servin-Rojas, Maximiliano
    Bolm, Louisa
    Lillemoe, Keith D.
    Fong, Zhi Ven
    Narayan, Raja R.
    Castillo, Carlos Fernandez-Del
    Qadan, Motaz
    JOURNAL OF SURGICAL RESEARCH, 2025, 307 : 33 - 41
  • [28] Impact of pancreatic ductal occlusion on postoperative outcomes in pancreatic head cancer patients undergoing neoadjuvant therapy
    Hidaka, Yoshifumi
    Tanoue, Shiroh
    Ayukawa, Takuro
    Takumi, Koji
    Noguchi, Hirotsugu
    Higashi, Michiyo
    Idichi, Tetsuya
    Kawasaki, Yota
    Kurahara, Hiroshi
    Mataki, Yuko
    Ohtsuka, Takao
    Koriyama, Chihaya
    JOURNAL OF GASTROENTEROLOGY, 2024, 59 (09) : 858 - 868
  • [29] Impact of Sarcopenia on Patients with Localized Pancreatic Ductal Adenocarcinoma Receiving FOLFIRINOX or Gemcitabine as Adjuvant Chemotherapy
    Mortier, Victor
    Wei, Felix
    Pellat, Anna
    Marchese, Ugo
    Dohan, Anthony
    Brezault, Catherine
    Barat, Maxime
    Fuks, David
    Soyer, Philippe
    Coriat, Romain
    CANCERS, 2022, 14 (24)
  • [30] Pancreatic ductal adenocarcinoma: time for a neoadjuvant revolution?
    Roberto Salvia
    Giuseppe Malleo
    Laura Maggino
    Michele Milella
    Claudio Bassi
    Updates in Surgery, 2020, 72 : 321 - 324
12345